Yan Xing

3PUBLICATIONS
8CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 30, 2021
Preclinical Mechanisms of Topical PRN473, a Bruton Tyrosine Kinase Inhibitor, in Immune-Mediated Skin Disease Models.

Yan Xing, Katherine A Chu, Jyoti Wadhwa

|Mar 06, 2021
Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease.

Claire L Langrish, J Michael Bradshaw, Michelle R Francesco

|Oct 16, 2015
A Small Molecule Inhibitor of ITK and RLK Impairs Th1 Differentiation and Prevents Colitis Disease Progression.

Hyoung-Soo Cho, Hyun Mu Shin, Helena Haberstock-Debic

Pageof 1

Frequent Collaborators

1 joint publications

Hyoung-Soo Cho

1 joint publications

Hyun Mu Shin

1 joint publications

Leslie J Berg

1 joint publications

Timothy D Owens